Sponsored Research
Teminioluwa A. Ajayi (Mentor: Svati H. Shah) of Cardiology has received an award from the American Heart Association for a project entitled "Student Scholarships in Cardiovascular Disease." Total funding will be $2,000.
Geoffrey S. Ginsburg of Cardiology has received an award (3U01-HG007282-04S2) from the National Institutes of Health for a project entitled "Implementation, Adoption, and Utility of Family History in Diverse Care Settings." Total funding will be $1,209,455.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "TO#6: Strategic Planning and Sustainability - Mod 4." Total funding will be $119,250.
Adrian F. Hernandez of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "PCORnet Phase II TO#12 Mod 2." Total funding will be $513,721.
Christopher Kontos of Cardiology has received an award (1U01-ES028187-01) from the National Institutes of Health for a project entitled "TIE2 Activation for the Treatment of Chemical-Induced Acute Lung Injury." Total funding will be $1,362,639.
Robert J. Mentz of Cardiology has received a sub-award (5R21-AG051077-02) through the Wake Forest University Health Sciences for a project entitled "Accrelerometry Substudy." Total funding will be $15,671.
Ebony L. Boulware of General Internal Medicine has received a sub-award (5UL1-TR001111-05) through the University of North Carolina - Chapel Hill for a project entitled "Regulatory Guidance for Academic Research of Drugs and Devices." Total funding will be $80,288.
Ebony L. Boulware of General Internal Medicine has received an award (3UL1-TR001117-05S1) from the National Institutes of Health for a project entitled "Enhancing the Manuscript Lifecycle from Keywords to Publication: Processes and Outcomes." Total funding will be $39,750.
Rahima Zennadi of Hematology has received an award from the National Institutes of Health for a project entitled "Role of RBC Reactive Oxygen Species and Their Vicious Cycle in Sickle Vasculopathy." Total funding will be $1,590,000.
Satkunanathan Balakumaran of Infectious Diseases has received a sub-award (2P01-DK056492-17A1) through the Baylor College of Medicine for a project entitled "Persistent HIV Infection in the Kidney- Administrative Core." Total funding will be $12,650.
Kimberly L. Blackwell of Medical Oncology has received an award through the Johns Hopkins University for a project entitled "TBCRC 40: Plasma Tumor DNA and Pathologic Complete Response In Early Stage, High-Risk Breast Cancer." Total funding will be $6,567.
Kevin C. Oeffinger of Medical Oncology has received a sub-award (5R01-CA187397-03) through the Sloan Kettering Institute for a project entitled "Exercise and Quality diet After Leukemia." Total funding will be $6,182.
Kevin C. Oeffinger of Medical Oncology has received a sub-award (1R01-CA204378-01) through the Fred Hutchinson Cancer Research Center for a project entitled "Improving Treatment of Cardiovascular Risk Factors in Childhood Cancer Survivors." Total funding will be $14,733.
Neil L. Spector of Medical Oncology has received an award from the Steven & Alexandra Cohen Foundation for a project entitled "Discovery of novel small molecule inhibitors targeting borrelia and bartonella." Total funding will be $3,000,000.
Tian Zhang of Medical Oncology has received a sub-award through the H. Lee Moffitt Cancer Center & Research Institute for a project entitled "Retrospective analysis of docetaxel in castration sensitive setting." Total funding will be $10,000.
Claude A. Piantadosi of Pulmonary, Allergy, and Critical Care Medicine has received an award (1R01-HL135239-01A1) from the National Institutes of Health for a project entitled "Mitochondrial quality control and alveolar damage resolution after acute lung injury." Total funding will be $1,590,000.
Industry-sponsored Clinical Trials
Terry A. Fortin of Cardiology has received an award from Actelion Pharmaceutical US, Inc for a project entitled "Uptravi® (SelexiPag): tHe usErs dRug rEgistry." Total funding will be $55,000.
William S. Jones of Cardiology has received an award from Medtronic, Inc. for a project entitled "Clinical Observation Program." Total funding will be $96,000.
Renato D. Lopes of Cardiology has received an award from Regeneron Pharmaceuticals, Inc. for a project entitled "Evinacumab (R1500-CL-1643)." Total funding will be $382,702.
Renato D. Lopes of Cardiology has received an award from Regeneron Pharmaceuticals, Inc. for a project entitled "Evinacumab (REGN1500)_R1500-CL-1629)." Total funding will be $106,078.
Sudarshan Rajagopal of Cardiology has received an award from United Therapeutics Corporation for a project entitled "Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension in Heart FAilure with Preserved Ejection Fraction (HFpEF)." Total funding will be $141,050.
Sunil V. Rao of Cardiology has received an award from Svelte Medical Systems, Inc. for a project entitled "OPTIMIZE." Total funding will be $42,277.
Andrew Wang of Cardiology has received an award from Medtronic, Inc. for a project entitled "Affairs of the Heart: Living with Hypertrophic and Dilated Cardiomyopathy." Total funding will be $1,000.
Paul S. Jowell of Gastroenterology has received an award from Medtronic, Inc. for a project entitled "Advanced Crt Implant Educational Program." Total funding will be $21,933.
Ranee Chatterjee Montgomery of General Internal Medicine has received an award from Epigenomics AG for a project entitled "Performance of Epi ProColon in Repeated Testing in the Intended Use Population (PERT) Study." Total funding will be $1,010,767.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from GlaxoSmithKline for a project entitled "Targeted Radioimmunotherapy for Untreated Patients with High Risk B Cell N-Hodgkin's Lymphoma." Total funding will be $1,600,109.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from Actinium Pharmaceuticals, Inc. for a project entitled "A Phase 1/11 Study of Lintuzumab-Ac225 in Older Patients with Untreated Acute Myeloid Leukemia." Total funding will be $73,916.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from Astex Therapeutics Ltd. for a project entitled "A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia." Total funding will be $324,534.
P. Kelly Marcom of Medical Oncology has received an award from Merck Sharp & Dohme for a project entitled "A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy for Triple Negative Breast Cancer (TNBC)." Total funding will be $585,739.
Andrew B. Nixon of Medical Oncology has received an award from Leadiant Biosciences, Inc. for a project entitled "Anti-Tumor Effects of locally and Systemically Administered EZN-2279 monotherapy in a murine model of Colorectal Carcinoma." Total funding will be $70,780.
Thomas Stinchcombe of Medical Oncology has received an award from Alliance Foundation Trials, LLC for a project entitled "A Randomized Phase II Study Evaluating Pembrolizumab vs Topotecan in the Second-line Treatment of Patients with Small Cell Lung Cancer." Total funding will be $95,625.
Thomas Stinchcombe of Medical Oncology has received an award from the Pfizer, Inc. for a project entitled "A Phase 3, Randomized, Open-Label Study Of Lorlatinib (Pf-06463922) Monotherapy Versus Crizotinib Monotherapy In The First-Line Treatment Of Patients With Advanced Alk-Positive Non-Small Cell Lung Cancer." Total funding will be $231,172.
Tian Zhang of Medical Oncology has received an award from The Prostate Cancer Clinical Trials Consortium for a project entitled "Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)." Total funding will be $12,100.
Alice L. Gray of Pulmonary, Allergy, and Critical Care Medicine has received an award from Gilead Sciences, Inc. for a project entitled "Lung Transplantation in Chronic HCV Infection with Post Transplant EPCLUSA Treatment." Total funding will be $122,209.
Kamran Mahmood of Pulmonary, Allergy, and Critical Care Medicine has received an award from the CareFusion Corporation for a project entitled "Current Trends in Pleural Disease Management 2017." Total funding will be $5,000.
Scott M. Palmer of Pulmonary, Allergy, and Critical Care Medicine has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "Premier IPF 2." Total funding will be $999,134.
Timothy Scialla of Pulmonary, Allergy, and Critical Care Medicine has received an award from Sanofi US for a project entitled "Open-label extension study to evaluate the long-term safety and tolerability of dupilumab in patients with asthma who participated in a previous dupilumab asthma clinical study." Total funding will be $333,200.
Laurie D. Snyder of Pulmonary, Allergy, and Critical Care Medicine has received an award from Teva Pharmaceutical Industries, Ltd for a project entitled "eConnectivity COPD Study LOI." Total funding will be $3,467,322.